Skip to main content
Shehabaldin Alqalyoobi, MD, Pulmonology, Greenville, NC

ShehabaldinAlqalyoobiMD

Pulmonology Greenville, NC

Critical Care Medicine, Interstitial Lung Diseases

Assistant Professor of Medicine

Dr. Alqalyoobi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alqalyoobi's full profile

Already have an account?

Education & Training

  • University of Louisville
    University of LouisvilleMS, Biostatistics, 2020 - 2023
  • University of California Davis Health
    University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 2016 - 2019
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2013 - 2016
  • Arabian Gulf University College of Medicine
    Arabian Gulf University College of MedicineClass of 2009

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2019 - 2024
  • CA State Medical License
    CA State Medical License 2016 - 2019
  • MO State Medical License
    MO State Medical License 2013 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease
  • National Board of EchocardiographyCritical Care Echocardiography (Diplomate)

Awards, Honors, & Recognition

  • Outstanding Pulmonary disease faculty member of the year The Brody School of Medicine at East Carolina University, 2021
  • California Thoracic Society Scholar award California Thoracic Society, 2019
  • The American Federation for Medical Research Henry Christian Award American Federation for Medical Research, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • New Approved Medications for Idiopathic Pulmonary Fibrosis  
    Alqalyoobi S, Salzman G, Current Drug Therapy, 12/2015

Press Mentions

  • Plasma Biomarkers of Idiopathic Pulmonary Fibrosis May Predict Survival
    Plasma Biomarkers of Idiopathic Pulmonary Fibrosis May Predict SurvivalSeptember 26th, 2019

Professional Memberships